Today: 7 February 2026
Subscribe

AMD Stock Soars on AI Boom – November 2025 Analysis and Forecast

AMD Stock Today (Nov. 17, 2025): TD Cowen Reaffirms $290 Target as GPU Price Jitters Hit AI Favorite

AMD stock price today, 17 November 2025 Advanced Micro Devices (NASDAQ: AMD) is trading lower today as Wall Street digests another wave of AI‑related headlines and a fresh rumor about GPU price hikes. Even with today’s pullback, AMD remains up sharply year‑to‑date and is still priced for very high growth expectations in AI and data center computing. The key AMD headlines on November 17, 2025 Here are the main news items specifically about AMD stock today, 17.11.2025, that traders are reacting to: Taken together, today’s news flow is overwhelmingly about AI: massive long‑term opportunity, big partnerships, and ambitious targets —
17 November 2025
Expedia Group (EXPE) Today: Google AI Partnership, Dividend Deadline and Analyst Upgrades — November 17, 2025

Expedia Group (EXPE) Today: Google AI Partnership, Dividend Deadline and Analyst Upgrades — November 17, 2025

Published: November 17, 2025 Expedia Group, Inc. (NASDAQ: EXPE) is in the spotlight today as investors digest a potent mix of news: a high‑profile partnership with Google’s new AI travel experience, a looming dividend deadline, fresh analyst price‑target hikes and big moves by institutional shareholders. At the same time, the stock is trading lower intraday as markets reassess what AI‑driven travel search means for online travel agencies. Key takeaways for Expedia Group on November 17, 2025 Google’s new AI travel experience lifts Expedia — and rattles investors The biggest strategic headline today comes from Google’s own product blog. In a
17 November 2025
·
Apple Stock Near Record Highs as iPhone 17 Demand Soars – Analysis & 2025–2026 Forecast

Apple Stock Today, November 17, 2025: AAPL Slips as Buffett Trims Stake, Legal Risks Mount and CEO Succession Looms

Apple (NASDAQ: AAPL) shares traded lower on Monday, November 17, 2025, as a cluster of high‑profile headlines – from Warren Buffett cutting his position again to a $634 million patent verdict and fresh CEO succession chatter – collided with already rich valuations. By the U.S. session on Monday, Apple stock was hovering in the high‑$260s, down roughly 1.5–2% from Friday’s close around $272.4, after trading between about $266.7 and $270.5 during the day. That still leaves AAPL near the top of its 52‑week range of $169.21 to $277.32, with a market value a little above $3 trillion. Yahoo Finance+2Macrotrends+2 How Apple
17 November 2025
·
Microsoft (MSFT) Stock Update & Insight Report – 2 Oct 2025

Microsoft News Today, November 17, 2025: AI Power Crunch, New Copilot Tools, Xbox Showcase and Key EU Rulings

Microsoft enters the week with a dense slate of announcements and headlines touching nearly every part of its business: AI and cloud partnerships, advertising and Copilot features, security updates, Xbox news, EU data‑protection decisions, and even nuclear‑powered data‑centers. Below is a curated, human‑readable roundup of the most important Microsoft stories dated 17 November 2025, with context for IT leaders, investors, regulators, and everyday users. 1. AI partnerships: Levi Strauss, Aalo Atomics and Dynatrace deepen Microsoft’s enterprise reach Levi Strauss & Co. rolls out a Teams “superagent” for employees Levi Strauss & Co. and Microsoft announced a wide‑ranging collaboration that puts AI
17 November 2025
·····
Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

On November 17, 2025, Annovis Bio, Inc. (NYSE: ANVS) released new Phase 3 data in early Parkinson’s disease showing that its lead drug candidate buntanetap halted cognitive decline and improved key Alzheimer’s-related biomarkers in a significant subset of patients.Annovis Bio+1 The update triggered a sharp rally in ANVS stock and put fresh attention on the company’s multi-disease neurodegeneration strategy. What Annovis Bio Announced Today Annovis Bio’s news centers on a deeper analysis of its Phase 3 study in early Parkinson’s disease, registered as NCT05357989.Annovis Bio+1 According to the company, buntanetap: In this subgroup with amyloid co‑pathology, patients were found to decline faster
17 November 2025
·
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Today, November 17, 2025: NVDA Slips as Wall Street Braces for High-Stakes Q3 Earnings

Nvidia stock (NASDAQ: NVDA) spent Monday under pressure as investors positioned for one of the most closely watched earnings reports of the year and digested fresh signs of profit‑taking in the crowded AI trade. By early afternoon on November 17, 2025, Nvidia shares were trading around $187–188, down roughly 1.3% from Friday’s close near $190.17. The stock has traded between about $185.0 and $192.3 today on heavy volume north of 85 million shares, underscoring just how central Nvidia has become to overall market sentiment. Yahoo Finance At the index level, U.S. markets were choppy: the S&P 500 and Nasdaq hovered slightly lower while traders weighed the upcoming Nvidia earnings
17 November 2025
··
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla Stock Today (Nov 17, 2025): TSLA Rises on Stifel’s $508 Target; California Class Action Reversed; Syrah Graphite Deal Extended

Updated Nov 17, 2025 At a glance Tesla stock price today Tesla shares were ~$419.61, up about 3.8% as of 17:30 UTC on Monday, November 17. The stock opened at $399.06 and traded between $397.39 and $423.77 so far today (volume ~55.2 million). For context, TSLA trades roughly 14% below its 52‑week high of $488.54 and about 96% above its 52‑week low of $214.25. Macrotrends What’s moving TSLA on Nov 17, 2025 1) Stifel’s $508 target and the robotaxi/FSD story Stifel raised its Tesla price target to $508 (from $483), arguing that growing Full Self‑Driving (FSD) adoption and a ramping
17 November 2025
·
Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025

Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025

Applied Therapeutics Inc. (NASDAQ: APLT) is back on traders’ radar today, with its penny stock surging on enormous volume despite intense regulatory uncertainty and a stretched balance sheet. On November 17, 2025, APLT is trading like a biotech rollercoaster: pre‑market gains, intraday spikes of 30–70%, and tens of millions of shares changing hands as investors reassess the company’s prospects after last week’s Q3 update and fresh analyst commentary. Benzinga+2Benzinga+2 Below is a detailed look at everything that matters about Applied Therapeutics today, plus the context behind the move. Key Takeaways 1. What Happened to APLT Today? Pre‑market and intraday action
17 November 2025
·
Alibaba (BABA) Stock Today, Nov. 17, 2025: Shares Rebound on Qwen AI App Launch as Washington Scrutiny Intensifies

Alibaba (BABA) Stock Today, Nov. 17, 2025: Shares Rebound on Qwen AI App Launch as Washington Scrutiny Intensifies

Dateline — Monday, November 17, 2025. Alibaba’s U.S.–listed shares were higher at mid‑day after the company pushed deeper into consumer AI with a public beta of its new Qwen app, even as political pressure in Washington escalated following last week’s allegation that Alibaba aids China’s military—an allegation the company denies. Key takeaways Market snapshot: BABA on Monday BABA changed hands around $159.81 at mid‑session in New York, up roughly $6.01 on the day. The stock’s intraday high/low stood near $160.94/$157.11, respectively, with volume above 11 million shares by early afternoon. For context, Friday (Nov. 14) saw the ADRs close at
17 November 2025
··
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle Stock Today (Nov 17, 2025): ORCL Slips as Credit Hedges Rise; Jefferies Reaffirms $400 Target and 80% Upside

Published: November 17, 2025 Key takeaways What moved Oracle stock today Jefferies sticks with $400 target, sees selloff as overdone.In a note published this morning, Jefferies’ Brent Thill reaffirmed a $400 target on Oracle, framing the recent drawdown as an opportunity. The call cites a still‑large non‑OpenAI backlog and argues Oracle’s capex approach limits upfront cash strain versus owning all the infrastructure outright. MarketWatch Hedging picks up in credit markets—Oracle included.An exclusive from Reuters says Saba Capital has been selling CDS protection on Oracle, Microsoft, Meta, Amazon, and Alphabet to banks seeking to hedge exposure to the sector’s accelerating, debt‑financed
17 November 2025
Amazon (AMZN) Stock Analysis & Forecast – November 2025 Update

Amazon Stock Today (AMZN): $15B Bond Sale Weighs on Shares; Order Book Near $80B — Nov. 17, 2025

Amazon (NASDAQ: AMZN) traded modestly lower at midday on Monday as the company launched its first U.S. dollar bond sale in three years—an issuance that swelled to about $15 billion amid heavy demand. As of 12:30 p.m. ET (17:30 UTC), AMZN changed hands at $233.53, down roughly 0.5% on the session. Bloomberg Key numbers (intraday) What’s moving AMZN today A jumbo bond sale to feed AI and growth spending. Amazon filed a six‑part U.S. investment‑grade offering that initially circulated around $12 billion, with the longest 40‑year tranche first guided at about +115 bps over comparable Treasuries. By afternoon, reporting indicated
17 November 2025
Meta Platforms (META) November 2025 Stock Analysis: AI-Fueled Growth vs. Rising Costs

Meta (META) Stock Today — Nov. 17, 2025: Red Sea Cable Delays, Renewable-Energy Milestone, and a Pixel Lawsuit Settlement

Published Nov. 17, 2025 Quick take: Meta Platforms (NASDAQ: META) traded modestly lower on Monday as investors weighed fresh infrastructure and legal headlines against a calm-but-cautious broader market tone ahead of key U.S. data and Nvidia earnings later this week. As of 17:30 UTC, META changed hands at $607.11 (intraday $603.36–$613.00; open $609.35; market cap ≈$1.85T). What moved META today Price action at a glance (intraday) The story behind today’s headlines 1) Red Sea cable delays: why investors care Bloomberg’s report that Meta and Google have paused segments of Red Sea cable work because of heightened security risks puts a
17 November 2025
·
1 … 2,153 2,154 2,155 2,156 2,157 … 2,716

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
Go toTop